| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 05/14/2008 | EP1427748B1 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 05/13/2008 | US7371741 Angiogenesis inhibitor |
| 05/13/2008 | CA2322847C Steroid derived antibiotics |
| 05/08/2008 | US20080108122 Microchemical nanofactories |
| 05/07/2008 | EP1513588B1 Use of new etonogestrel esters |
| 04/30/2008 | EP1916254A2 17alpha-alkyl-17beta-oxy-estratriene and intermediates for its production, use of 17alpha-alkyl-17beta-oxy-estratriene for manufacturing medicine and pharmaceutical preparations |
| 04/29/2008 | US7365218 Process for preparing guggulsterones |
| 04/24/2008 | WO2007118717A3 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL) |
| 04/23/2008 | EP1913012A2 Oligomers of cholesterol, cholesterol sulfate and cholesterol esters, and medicaments containing the same |
| 04/22/2008 | US7361645 Androgenic 7-substituted 11-halogen steroids |
| 04/22/2008 | CA2150642C Tablet, capsule, or granule comprising desogestrel |
| 04/17/2008 | WO2008011005A3 Antiangiogenic agents |
| 04/16/2008 | EP1910402A2 3-ester prodrugs of estradiol |
| 04/16/2008 | EP1910401A2 3-ester prodrugs of ethynylestradiol |
| 04/16/2008 | EP1910398A1 17-alpha-substituted derivatives of estradiol with wound-healing activity |
| 04/16/2008 | CN101161669A Method for synthesizing 2-methoxy estradiol |
| 04/16/2008 | CN100381457C 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos |
| 04/15/2008 | US7358379 Steroid conjugates, preparation thereof and the use thereof |
| 04/10/2008 | WO2007140917A3 CRYSTALLINE FORMS OF 11 ß-(4-ACETYLPHENYL)-20,20,21,21,21-PENTAFLUOR-17- HYDROXY-19-NOR-17α-PREGNA-4,9-DIEN-3-ONE |
| 04/10/2008 | US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's |
| 04/09/2008 | CN101160160A A process for the isolation of pharmacologically active principles of vegetable and animal origin |
| 04/08/2008 | US7355056 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents |
| 04/02/2008 | CN100378116C High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one |
| 04/02/2008 | CN100377711C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 04/01/2008 | US7351699 Use of DHEA or precursors or metabolic derivatives thereof as a depigmenting agent |
| 03/20/2008 | WO2008032131A1 Process for the selective isolation, purification and separation of monohydroxylated 3,17-diketo-steroid compounds |
| 03/20/2008 | US20080070881 Prostate Cancer Treatment |
| 03/20/2008 | US20080070880 Specific glucocorticosteroid compound having anti-inflammatory activity |
| 03/12/2008 | CN101139408A Method for synthesizing crinovaryl selective adsorption functional material |
| 03/11/2008 | CA2382489C Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 03/06/2008 | US20080058301 Therapy for prostate cancer; administering androgen receptor |
| 03/05/2008 | CN100372864C Process for the preparation of 7-alpha-methylsteroids |
| 02/21/2008 | US20080045490 Pharmaceutical Compositions |
| 02/20/2008 | CN100369927C Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 02/14/2008 | US20080039643 Process for the Preparation of Phenolic Hydroxy-Substituted Compounds |
| 02/13/2008 | EP1353938B1 Androgenic 7-substituted 11-halogenated steroids |
| 02/13/2008 | CN100368427C Method for production of 4-(17 alpha-substituted-3-oxoestra-4,9-dien-11-yl) benzaldehyd-(1E or 12)-oximes |
| 02/13/2008 | CN100368426C Anthraquinone ramification of rhubarb, preparing method and combination of medication by using the ramification as active ingredient |
| 02/13/2008 | CN100368425C 6,7-oxygenated steroids and uses related thereto |
| 02/06/2008 | EP1883648A1 Process for the preparation of pure crystalline tibolone |
| 02/05/2008 | CA2283597C Reduced cortisol conjugates |
| 01/31/2008 | US20080027237 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein |
| 01/29/2008 | US7323454 Etonogestrel undecanoate, decanoate and/or dodecanoate; male and female contraception and hormone replacement therapy; endometriosis, menorrhagia, meno-metrorrhagia, pre-menstrual syndrome and dysmenorrhoea |
| 01/29/2008 | CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/24/2008 | WO2008011005A2 Antiangiogenic agents |
| 01/24/2008 | US20080021231 Novel compounds |
| 01/24/2008 | US20080021006 steroids used as androgen receptor modulators, for the treatment prostate cancer, benign prostatic hyperplasia or breast cancer |
| 01/22/2008 | CA2322967C Prophylactic, therapeutic agent for osteoporosis |
| 01/17/2008 | US20080015360 2,3-Dimethyl-1-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-imidazol-3-ium chloride; intermediate for preparing androstane-type glucocorticoid receptor agonists |
| 01/17/2008 | US20080015173 Estrogen Receptor Modulators |
| 01/10/2008 | US20080009472 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/09/2008 | CN101100480A New etonogestrel esters |
| 01/09/2008 | CN100360550C Liver X receptor agonists |
| 01/08/2008 | CA2175603C Estrogen compositions and methods for neuroprotection |
| 01/03/2008 | US20080004250 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 12/27/2007 | US20070299268 Process for the Preparation of Estrone and/or Estradiol-Derivates |
| 12/27/2007 | US20070298456 Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof |
| 12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
| 12/26/2007 | CN101092442A Steroid compounds having contraceptive and anti-osteoporosis activity |
| 12/26/2007 | CN100357311C 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 12/20/2007 | DE19943708B4 Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New C13-substituted estra-1,3,5 (10) -triene-3-yl-sulfamate, to their preparation and to pharmaceutical compositions containing these compounds, method |
| 12/19/2007 | CN101089011A Process of producing methyltestosterone with Grignard reagent as material |
| 12/19/2007 | CN100355771C Process for the synthesis of high purity D-(17alpha)-13-ethyl-17 -hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime |
| 12/18/2007 | CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer |
| 12/13/2007 | CA2654126A1 Crystalline forms of 11.beta.-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17.alpha.-pregna-4,9-dien-3-one |
| 12/12/2007 | CN101085803A Androstane compound and its preparation method and application |
| 12/12/2007 | CN101085800A Method for preparing 11alpha-hydroxy-4-ene-3,17-androstenedione |
| 12/12/2007 | CN100354299C Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 12/06/2007 | WO2007118711B1 17α-SUBSTITUTED 4-(3-OXOESTRA-4,9-DIEN-11β-YL)-BENZOIC ACID, ITS DERIVATIVES AND PROCESS FOR ITS PRODUCTION |
| 12/06/2007 | US20070281912 treating with a mixture comprising nomegestrol acetate and estradiol valerate or estradiol; side effect reduction |
| 12/06/2007 | CA2667854A1 Tagging reagents and methods for hydroxylated compounds |
| 12/05/2007 | EP1862546A1 Enhanced virus-mediated dna transfer |
| 12/05/2007 | EP1862468A1 Crystalline 11beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one |
| 11/27/2007 | US7300926 Bioavailability; prevention therapy of osteoporosis ; menopause therapy; side effect reduction |
| 11/13/2007 | CA2480004C Process for production of steroid crystals, crystals obtained thereby and their use in pharmaceutical preparations |
| 11/07/2007 | EP1263770B1 6-oxygenated steroidal estrogens with aromatic a and b rings |
| 11/06/2007 | US7291610 Estrogenic compounds as anti-mitotic agents |
| 11/06/2007 | US7291609 Specific glucocorticosteroid compound having anti-inflammatory activity |
| 10/31/2007 | EP1539795B1 Crystalline 17beta-hydroxy-7alpha-(5'-methyl-2'-furyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma-lactone |
| 10/31/2007 | CN100345862C Steroid compounds preparation method |
| 10/30/2007 | US7288536 For therapy of skin diseases such as eczema, psoriasis, allergic dermatitis neurodermatitis, pruritis and hypersensitivity reactions; inflammatory conditions of the nose, throat or lungs such as asthma (including allergen-induced asthmatic reactions), rhinitis (including hayfever), nasal polyps |
| 10/30/2007 | CA2382106C Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 10/25/2007 | WO2007118717A2 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL) |
| 10/25/2007 | WO2007118711A1 17α-SUBSTITUTED 4-(3-OXOESTRA-4,9-DIEN-11β-YL)-BENZOIC ACID, ITS DERIVATIVES AND PROCESS FOR ITS PRODUCTION |
| 10/25/2007 | CA2648537A1 Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil) |
| 10/24/2007 | EP1846434A1 NANDROLONE 17ß-CARBONATES |
| 10/24/2007 | CN101061132A Method for preparing 17- hydroxy- 6beta, 7beta; 15beta, 16beta- bisacrylamide- 17alpha- pregnane- 4- ene- 3- ketone- 21- carboxylate gamma- lactone and key intermediate used for the said method |
| 10/23/2007 | CA2280041C Antigestagenic steroids with a fluorinated 17.alpha.-alkyl chain |
| 10/23/2007 | CA2263757C Method to obtain oestrogens from mare's urine |
| 10/17/2007 | EP1392713B1 Liver x receptor agonists |
| 10/17/2007 | CN100343269C Synthesis of estetrol via estrone derived steroids |
| 10/11/2007 | DE102005059222B4 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen 11ß-Benzaldoximderivate of D-Homoestra-4,9-dien-3-ones |
| 10/04/2007 | WO2007069039A3 A process for converting 17 substituted androsta-1,4,9(11)-triene-3-ones to 17 substituted 3-hydroxyestra-1,3,5(10),9(11)-tetraenes |
| 10/04/2007 | US20070232576 Sulfated molecular umbrellas as anti-HIV and anti-HSV agents |
| 10/03/2007 | EP1418921B1 Anti-tumour 2-alkoxyestradiol sulfamates |
| 10/02/2007 | US7276513 Steroidal compounds for inhibiting steroid sulphatase |
| 09/27/2007 | US20070225512 Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex |
| 09/26/2007 | CN101041681A Preparation and application of 5alpha-androstene-7-methyl-3-hydroxy-17-ketone |
| 09/26/2007 | CN100339486C Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 09/19/2007 | EP1834959A2 Tert-butyl-substituted aromatic steroids having cytoprotective activity |